We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,651.00
Bid: 1,651.00
Ask: 1,652.00
Change: 11.50 (0.70%)
Spread: 1.00 (0.061%)
Open: 1,650.50
High: 1,656.00
Low: 1,637.00
Prev. Close: 1,639.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

9 Sep 2019 09:52

UPDATE 2-UK bluechips give up gains as sterling strengthens

* FTSE 100 down 0.6%, FTSE 250 down 0.1%* Multinationals drop as pound gains* ABF falls after weak trading update* Shopping centre operator Intu jumps on deal report (Adds company news items, updates share moves)By Muvija M and Indranil SarkarSept 9...

Read more
5 Sep 2019 09:29

REFILE-UPDATE 2-Strong sterling knocks FTSE 100 despite trade lull

(Reinstates dropped word 'said' in para 7)* FTSE 100 down 0.6%, FTSE 250 up 0.2%* Exporter stocks fall as pound surges* CYBG tanks on mid-caps* Online retailer Boohoo jumps after forecast upgrade* Industrials up on upbeat forecast from European peers...

Read more
5 Sep 2019 09:29

UPDATE 2-Strong sterling knocks FTSE 100 despite trade lull

* FTSE 100 down 0.6%, FTSE 250 up 0.2%* Exporter stocks fall as pound surges* CYBG tanks on mid-caps* Online retailer Boohoo jumps after forecast upgrade* Industrials up on upbeat forecast from European peers (Adds news, quote, updates closing price...

Read more
4 Sep 2019 09:32

BROKER RATINGS SUMMARY: Deutsche Bank Raises BHP And Cuts Antofagasta

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:----------FTSE 100----------DEUTSCHE BANK RAISES BHP

Read more
3 Sep 2019 12:59

Tuesday broker round-up

(Sharecast News) - easyJet: Kepler Cheuvreux downgrades to reduce with a target price of 820p.

Read more
3 Sep 2019 09:40

BROKER RATINGS SUMMARY: Deutsche Bank Starts Taylor Wimpey At Buy

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:----------FTSE 100----------DEUTSCHE BANK INITIATES TAYLOR WIMPEY

Read more
3 Sep 2019 08:49

LONDON MARKET OPEN: Ferguson-Wolseley Rises; Pound Falls Below USD1.20

(Alliance News) - Stock prices in London opened mixed on Tuesday, with Ferguson the best blue-chip performer after the company decided to split its UK and US operations, while the pound fell below

Read more
2 Sep 2019 13:16

Monday broker round-up

(Sharecast News) - Beazley: UBS upgrades to buy with a target price of 650p.

Read more
2 Sep 2019 12:02

Former Glaxo Vice President To Lead C4X Discovery Advisory Network

(Alliance News) - C4X Discovery Holdings PLC on Monday said it is forming a drug discovery advisory network chaired by "renowned industry veteran" Robin Carr.Shares in C4X were up

Read more
2 Sep 2019 09:41

BROKER RATINGS SUMMARY: Goldman Sachs Says Buy Unilever, Sell M&S

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday afternoon:----------FTSE 100----------GOLDMAN SACHS WITH

Read more
28 Aug 2019 09:37

BROKER RATINGS SUMMARY: UBS Raises Greggs; Peel Hunt Lifts Chesnara

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday afternoon and Wednesday morning:----------FTSE 100----------KEPLER RAISES

Read more
23 Aug 2019 07:46

GlaxoSmithKline's Dreamm-2 Multiple Myeloma Trial Results Encouraging

(Alliance News) - GlaxoSmithKline PLC on Friday reported positive headline results from its Dreamm-2 study of belantamab mafodotin in multiple myeloma.The study, which involved 196 patients

Read more
23 Aug 2019 07:29

GlaxoSmithKline reveals positive results from belantamab mafodotin trial

(Sharecast News) - GlaxoSmithKline announced positive headline results from the pivotal 'DREAMM-2' open-label, randomised study of two doses of belantamab mafodotin on Friday.

Read more
22 Aug 2019 08:20

Glaxo's ViiV Reports Positive Study Results Of HIV-Treatment Regimen

(Alliance News) - GlaxoSmithKline PLC on Thursday said ViiV Healthcare reported positive headline results from its global phase III ATLAS-2M study.ViiV Healthcare is a specialist HIV owned

Read more
22 Aug 2019 07:29

GlaxoSmithKline upbeat on latest test results from ViiV Healthcare

(Sharecast News) - GlaxoSmithKline reported on Thursday that its specialist HIV company ViiV Healthcare had announced positive headline results from its phase 3 'ATLAS-2M' study of the investigational, long-acting, injectable, two-drug regimen (2DR) of its cabotegravir and Janssen's rilpivirine for the treatment of HIV.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.